Duality Advisers’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-26,166
Closed -$2.15M 531
2022
Q4
$2.15M Buy
+26,166
New +$2.16M 0.25% 135
2022
Q1
Sell
-5,171
Closed -$314K 611
2021
Q4
$314K Sell
5,171
-13,524
-72% -$806K 0.03% 441
2021
Q3
$1.19M Buy
+18,695
New +$1.18M 0.09% 320
2020
Q4
Sell
-13,240
Closed -$390K 525
2020
Q3
$390K Buy
+13,240
New +$384K 0.02% 503

Other funds holding ACHC

Duality Advisers's ACHC Position: Q1 2023 in Review

Duality Advisers sold out of Acadia Healthcare (ACHC) in Q1 2023, closing a stake of 26,166 shares — an estimated $2.15M sold.

Duality Advisers first reported a position in ACHC in Q3 2020 and held it in 4 quarters. The position peaked at $2.15M in Q4 2022. 310 funds tracked by Wall St. Rank hold ACHC as of Q1 2023.

  • Duality Advisers reported no remaining Acadia Healthcare position as of Q1 2023 after selling out during the quarter.
  • Duality Advisers sold 26,166 Acadia Healthcare shares in Q1 2023, an estimated $2.15M.
  • Duality Advisers first reported a position in Acadia Healthcare in Q3 2020 and held it in 4 quarters.
  • Duality Advisers's Acadia Healthcare position peaked at $2.15M in Q4 2022.
  • 310 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2023.

Based on Duality Advisers's 13F filing for Q1 2023, filed 27 Jun 2023.